DIVIS LABORATORIES
|
The Current P/E Ratio of DIVIS LABORATORIES is 76.18.
Share Price | ₹5,931.0 | Feb 10,2025 |
Market Cap | ₹157,468.1 Cr | |
Earnings-TTM | ₹2,067.0 Cr | TTM-Consolidated Results |
Price/Earnings | 76.18x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of DIVIS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹157,468.1 Cr] as on Feb 10,2025
(/) Earnings [ ₹2,067.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 76.18x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay 76.18 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DIVIS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DIVIS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of DIVIS LABORATORIES
PE Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 44.87x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 41.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2024 at 56.92x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 38.33x.
How does DIVIS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
DIVIS LABORATORIES | 2,067.00 | 76.18 | 157,468.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.19 | 415,697.0 |
CIPLA LTD | 5,000.43 | 23.55 | 117,778.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.77 | 101,871.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 21.13 | 97,046.2 |
MANKIND PHARMA LTD | 2,050.73 | 50.44 | 103,442.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 57.99 | 107,984.0 |
LUPIN LTD | 2,651.94 | 37.35 | 99,049.5 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.53 | 68,348.7 |
ABBOTT INDIA LTD | 1,334.46 | 47.23 | 63,030.1 |
ALKEM LABORATORIES LTD | 2,197.47 | 26.12 | 57,402.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DIVIS LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.77x |
Max industry PE | 76.18x |
Median industry PE | 36.19x |
Average industry PE | 37.68x |
You may also like the below Video Courses